Intrinsic
Screener
Valuation
Movers
Economy
Bonds
Institutions
Business Summaries
Updates
Go
Sign In
Screener
Summaries
Updates
Institutions
Sign In
More
↑
Overview
Financials
Chart
Business Summary
Filings
Ownership
Valuation
Kiniksa Pharmaceuticals International, plc
(KNSA)
Pharmaceutical Preparations
Latest Price
$75.15
TTM P/E
82.58
Normalized P/E
158.65
Div Yield
--
Book Value
7.92
P/B Ratio
9.49
Valuation metrics
adjust assumptions →
EPS:
$0.75
Book value / share:
$7.19
Formula:
√(22.5 × EPS × BVPS)
Graham Number
$11.01
85% downside
Base FCF:
$19M (median of recent 5yr)
Growth:
25%/yr (median YOY, capped at 25%)
Discount rate:
10%
Terminal growth:
3%
Projection horizon:
10 years
DCF Fair Value
$23.42
69% downside
EPS:
$0.75
Target P/E:
84×
Formula:
EPS × P/E
P/E Fair Value
$63.00
16% downside